FDAQRC (PRIVATE.FDAQRC)

Overall impact
D (30)

Commentary

FDAQRC is a below-average overall performer. With a 'D' rating of 30.3 for overall impact (bottom 25% of all companies), FDAQRC ranks 90th out of 101 industry peers, behind GXP Engaged, Bureau Veritas, Bain and 86 others, and ahead of Your.Online, Caci International, Agility Recovery and 8 others. On top material causes for FDAQRC's industry (Professional Services), FDAQRC performs poorly in Accountable Institutions (39.9 score), No Poverty (18.7), Safety From Violent Conflict (11.0) and 19 other causes where it received a 'D' or 'F' score. FDAQRC did not receive an 'A' rating on any cause.
Impact
Cause PRIVATE.FDAQRC
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2009
Employees
68
Sector
Industrials
Industry
Professional Services
Sub-industry
Research & Consulting Services
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Texas, United States
Share classes
PRIVATE.FDAQRC
Description
FDAQRC offers specialized quality consulting, regulatory compliance and quality assurance for Pharmaceutical, Medical Device and Biotech companies. We provide customized, value-added solutions, processes and enhanced quality standards to optimize business efficiencies and minimize regulatory risk. We do more than audits; we collaborate with you to analyze your need and match the right expert to your situation. Our global team is recognized as experts in quality assurance and regulatory affairs providing expert advice to pharmaceutical, medical device and contract research organizations in pre-clinical, clinical and commercialized sectors.
Material causes
Ethos considers the following causes material for FDAQRC, based on its industry sub-industry Research & Consulting Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.